Tern PLC

  • ISIN: GB00BFPMV798
  • Land: Großbritannien

Nachricht vom 11.07.2018 | 09:00

Tern PLC: Thales and Device Authority officially launch solution to secure the Connected Health industry

Tern PLC

11-Jul-2018 / 08:00 GMT/BST


11 July 2018

Tern Plc ("Tern" or the "Company")

Thales and Device Authority officially launch solution to secure the Connected Health industry

Tern Plc (AIM: TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that Thales' healthcare IoT security solution, developed in conjunction with Tern's portfolio company Device Authority ("DA"), in which Tern has a 56.8% holding, has been officially launched by Thales.

The Company announced on the 22 June 2018 that Thales had commenced preliminary marketing of the healthcare IoT security blueprint, which integrates DA's KeyScaler platform with the Thales nShield Connect hardware security module, and the official launch represents the next step in Thales' sales strategy.

DA is forecasting for the Thales strategic partnership to start to contribute to revenues in 2018.

Tern CEO, Al Sisto, said: "This opens up a new revenue stream to DA in a market which clearly needs protection from cyber-attacks. The use of IoT in the healthcare industry is increasing and therefore I am delighted to see DA and Thales launching this technology to deliver effective protection to patients."

**ENDS**

Enquiries

Tern Plc

Al Sisto/Sarah Payne
via Redleaf Communications
Redleaf Communications

Elisabeth Cowell/ Fiona Norman
Tel: 020 3757 6880


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

show this

GBC-Fokusbox

UniDevice AG: Rekord-Ergebnis in 2018

Nach starkem Schlussspurt hat die UniDevice AG in 2018 Umsatz und Ergebnis deutlich gesteigert. Der B2B-Broker für hochpreisige Smartphones sollte auch künftig eine hohe Nachfrage verzeichnen und von der Ausnutzung unterschiedlicher Preisniveaus in den verschiedenen Ländern profitieren. Der Umsatz soll 2019 auf mindestens 380 Mio. € und in 2020 auf mindestens 410 Mio. € ansteigen, nachdem 2018 317 Mio. € erreicht wurden. Bei einem ermittelten Kursziel in Höhe von 2,35 € lautet das Rating KAUFEN.

News im Fokus

Fresenius Medical Care gibt Ausscheiden von Finanzvorstand Michael Brosnan bekannt

20. Februar 2019, 10:29

Aktueller Webcast

Ströer SE & Co. KGaA

Vorläufige Geschäftszahlen 2018

26. Februar 2019

Aktuelle Research-Studie

Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index

20. Februar 2019